Letter to the Editor: Transcatheter aortic valve implantation beyond 85 years: Age is no longer the limiting factor, but risk stratification still matters
World Journal of Cardiology · 26.07.2026 · 18 (7)
DOI: 10.4330/wjc.117884 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Cardiology, online erschienen am 26.07.2026. Verfasst von Nikolaos Ktenopoulos und 5 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
The rapid expansion of transcatheter aortic valve implantation (TAVI) has fundamentally reshaped the management of severe aortic stenosis in elderly and high-risk populations. However, evidence specifically addressing outcomes in the very elderly, particularly patients aged 85 years and older, needs further exploration. In this context, the retrospective cohort study by Algethami et al provides interesting and clinically relevant insights into mid-term survival following TAVI in this advanced-age group. The authors report favorable survival rates at 1 year and 3 years, reinforcing the concept that chronological age alone should not constitute a contraindication to TAVI. Importantly, their findings highlight obesity as a significant predictor of early mortality, underscoring the need for refined risk stratification beyond conventional age-based decision-making. This article discusses the implications of these results within the evolving landscape of structural heart disease management, emphasizing the shift from age-centered to biology- and comorbidity-driven patient selection. Furthermore, it explores how factors such as frailty, metabolic burden and non-cardiac comorbidities should increasingly inform multidisciplinary heart team decisions. As TAVI continues to expand into older populations, studies such as this one help define realistic expectations, guide individualized care and support evidence-based expansion of indications in the very elderly.
Zitieren
APA
Ktenopoulos, N., Milaras, N., Apostolos, A., Tsioufis, C., Toutouzas, K., & Sideris, S. (2026). Letter to the Editor: Transcatheter aortic valve implantation beyond 85 years: Age is no longer the limiting factor, but risk stratification still matters. World Journal of Cardiology, 18(7). https://doi.org/10.4330/wjc.117884
Vancouver
Ktenopoulos N, Milaras N, Apostolos A, Tsioufis C, Toutouzas K, Sideris S. Letter to the Editor: Transcatheter aortic valve implantation beyond 85 years: Age is no longer the limiting factor, but risk stratification still matters. World Journal of Cardiology. 2026;18(7). doi:10.4330/wjc.117884
BibTeX
@article{Ktenopoulos2026,
author = {Ktenopoulos, Nikolaos and Milaras, Nikias and Apostolos, Anastasios and Tsioufis, Constantinos and Toutouzas, Konstantinos and Sideris, Skevos},
title = {Letter to the Editor: Transcatheter aortic valve implantation beyond 85 years: Age is no longer the limiting factor, but risk stratification still matters},
journal = {World Journal of Cardiology},
year = {2026},
volume = {18},
number = {7},
doi = {10.4330/wjc.117884}
}
EUVIMED